Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024

BUY
$32.77 - $42.31 $196 - $253
6 New
6 $0
Q2 2018

Jul 27, 2018

SELL
$97.62 - $120.59 $110,505 - $136,507
-1,132 Closed
0 $0
Q4 2017

Feb 08, 2018

SELL
$104.5 - $126.38 $200,640 - $242,649
-1,920 Reduced 62.91%
1,132 $119,000
Q3 2017

Oct 12, 2017

SELL
$97.26 - $116.2 $235,563 - $281,436
-2,422 Reduced 44.25%
3,052 $344,000
Q2 2017

Aug 17, 2017

BUY
N/A
5,474
5,474 $613,000

Others Institutions Holding TARO

About TARO PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TARO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 37,584,600
  • Description
  • Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage...
More about TARO
Track This Portfolio

Track Advisory Services Network, LLC Portfolio

Follow Advisory Services Network, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advisory Services Network, LLC with notifications on news.